Pricing Log in Create free account

Abpro Holdings Inc. (ABPO) vs Kairos Pharma, Ltd. (KAPA)

Abpro Holdings Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. Abpro Holdings Inc. and Kairos Pharma, Ltd. are of similar size ($1.5M and $1.4M). Kairos Pharma, Ltd. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.5×. Across the 9 metrics below, Abpro Holdings Inc. leads on 8 and Kairos Pharma, Ltd. on 1.

Valuation

Metric ABPO KAPA Biotechnology median
P/E 0.55 n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.36 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 0.21 0.66
EV/Sales n/m n/m 9.02
Earnings yield 183.50% (399.90%) (32.88%)
Free cash flow yield (193.29%) (264.69%) (23.13%)

Profitability

Metric ABPO KAPA Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) (113.96%) (51.96%)
Return on assets 46.10% (104.32%) (46.06%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric ABPO KAPA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.15% (30.44%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABPO KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 11.98 4.97
Net debt to EBITDA 0.01 1.65 1.01

Dividend

Metric ABPO KAPA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABPO KAPA Biotechnology median
Market cap 1.42m 1.54m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack